{"id":"W7111640692","doi":"","title":"Lenvatinib with or without pembrolizumab versus chemotherapy for treatment of recurrent or metastatic head and neck squamous cell carcinoma that progressed on platinum therapy and immunotherapy: Phase 2 LEAP-009","year":2023,"lang":"en","type":"article","venue":"Research Explorer (The University of Manchester)","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Infection and Immunity","funders":"","keywords":"Lenvatinib; Pembrolizumab; Head and neck squamous-cell carcinoma; Chemotherapy; Head and neck cancer; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002501936,0.001266735,0.002159458,0.0005793259,0.0003749337,0.001286587,0.001169884,0.001488095,0.007815978],"category_scores_gemma":[0.001593241,0.0005795244,0.002135004,0.0003936752,0.0007116423,0.001347482,0.0005268626,0.003302011,0.0009786329],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00117654,"about_ca_system_score_gemma":0.002070075,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007744561,"about_ca_topic_score_gemma":0.002631524,"domain_scores_codex":[0.9991443,0.0004647819,0.00005078262,0.000122971,0.00008312887,0.0001340076],"domain_scores_gemma":[0.9991674,0.0001682088,0.0002081727,0.00007091457,0.0000515577,0.0003336633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9014249,0.02521659,0.001486363,0.000850078,0.001364877,0.00009221909,0.00008994617,0.001295016,0.006608179,0.0002700379,0.002564877,0.05873692],"study_design_scores_gemma":[0.8317086,0.1594042,0.003987371,0.0000736878,0.0005762485,0.000114941,0.00002616263,0.0007895226,0.000930249,0.0002114454,0.002158094,0.00001963112],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.973613,0.005747484,0.001006763,0.001313836,0.0004713587,0.009523916,0.002737995,0.0001693497,0.005416228],"genre_scores_gemma":[0.9673002,0.00389178,0.003304598,0.002424933,0.000502207,0.01110145,0.004712848,0.00005868191,0.00670334],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007815978,"threshold_uncertainty_score":0.02614707,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2480826967779937,"score_gpt":0.3949347036536521,"score_spread":0.1468520068756584,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}